An autologous cancer vaccine kit for veterinary patients, producing a personalized immunotherapy from the patient's own tumour tissue.
Torigen's VimClara is described as an autologous cancer vaccine kit for veterinary patients. A tumour collection kit and specialty pathology service produce a personalized cancer vaccine from the patient's own tumour tissue, distributed through the veterinary channel.
The offering competes directly with Gamgee on buyer, problem, and deployment: both deliver a personalized, patient-specific canine cancer immunotherapy through treating veterinarians rather than a fixed off-the-shelf product.
Adds products that compete with one of Torigen VimClara Autologous Cancer Vaccine Kit’s direct competitors but not with Torigen VimClara Autologous Cancer Vaccine Kit itself. They are shaded, and Linked Through names the direct competitor each one competes with.
| Attribute | Torigen VimClara Autologous Cancer Vaccine Kit | Gamgee Personalized mRNA Cancer Vaccine for Dogs | ELIAS Cancer Immunotherapy (ECI) | RosieVaccine Personalized mRNA Cancer Vaccine for Dogs | |
|---|---|---|---|---|---|
| Linked Through | — | Direct competitor | Gamgee Personalized mRNA Cancer Vaccine for Dogs | Gamgee Personalized mRNA Cancer Vaccine for Dogs | |
| Provider |  |  |  |  | |
| Founded | 2013 | 2026 | 2014 | — | |
| Sells To | Veterinarians and clinics | Individuals | Enterprise, Small Business | — | |
| Pricing Model | Fee for Service, Product Sales | Pre-Revenue | Recurring, Software | — | |
| Ownership | Private, Venture-backed | Private | Venture-backed | — |
Provider
Founded 2013
Sells To Veterinarians and clinics
Pricing Model Fee for Service, Product Sales
Ownership Private, Venture-backed
Provider
Founded 2026
Sells To Individuals
Pricing Model Pre-Revenue
Ownership Private
Linked Through Gamgee Personalized mRNA Cancer Vaccine for Dogs
Provider
Founded 2014
Sells To Enterprise, Small Business
Pricing Model Recurring, Software
Ownership Venture-backed
Linked Through Gamgee Personalized mRNA Cancer Vaccine for Dogs
Provider
Founded —
Sells To —
Pricing Model —
Ownership —
A personalized mRNA neoantigen cancer vaccine design service for dogs, built from the individual dog's tumour and normal sequencing.
A personalized autologous cancer immunotherapy for dogs, combining a vaccine made from the patient's own tumour with activated T-cell therapy.
A personalized mRNA neoantigen cancer vaccine design service for dogs, built from the individual dog's tumour and normal sequencing.
A personalized autologous cancer immunotherapy for dogs, combining a vaccine made from the patient's own tumour with activated T-cell therapy.